Droxidopa

CAS 23651-95-8

Visão geral

Droxidopa is used to treat neurogenic orthostatic hypotension (lightheadedness, dizziness, or fainting) caused by primary autonomic failure (eg, Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy

A Anant Labs fabrica e fornece impurezas de Droxidopa de alta qualidade para o mercado global. Nossas impurezas EP de Droxidopa são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Em Estoque

Droxidopa

CAS 23651-95-8Em Estoque

Dados Técnicos

CAS23651-95-8

Fórmula Mol.C₉H₁₁NO₅

Peso Mol.213.189 g/mol

IUPAC(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

SMILESC1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O

InChIInChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1

Chave InChIQXWYKJLNLSIPIN-JGVFFNPUSA-N

Note: We are upgrading our system, Cat No will change.

Sinônimos

droxidopa23651-95-8L-DOPS(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acidNortheraDOPSthreo-DopaserineL-threo-DOPSL-ThreodopsL-dihydroxyphenylserine